Capital Fund Management S.A. Makes New $9.88 Million Investment in Corteva, Inc. $CTVA

Capital Fund Management S.A. purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 146,153 shares of the company’s stock, valued at approximately $9,884,000.

Other hedge funds have also recently made changes to their positions in the company. Empirical Finance LLC boosted its stake in shares of Corteva by 0.6% in the 2nd quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after purchasing an additional 153 shares in the last quarter. Fox Run Management L.L.C. raised its position in Corteva by 5.1% in the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock worth $227,000 after purchasing an additional 164 shares during the period. IFG Advisory LLC raised its position in Corteva by 1.7% in the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock worth $660,000 after purchasing an additional 166 shares during the period. United Community Bank lifted its stake in Corteva by 10.5% in the third quarter. United Community Bank now owns 1,849 shares of the company’s stock worth $125,000 after purchasing an additional 176 shares during the last quarter. Finally, Binnacle Investments Inc boosted its position in Corteva by 54.7% during the second quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock valued at $38,000 after buying an additional 181 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.14% of the stock is owned by insiders.

Corteva Stock Performance

Corteva stock opened at $79.76 on Friday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The firm has a market cap of $53.64 billion, a P/E ratio of 50.48, a P/E/G ratio of 2.69 and a beta of 0.72. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.90. The firm has a 50-day moving average of $73.88 and a 200-day moving average of $69.20.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the previous year, the business earned $0.32 EPS. Corteva’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CTVA. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Corteva in a research note on Monday, December 29th. Mizuho increased their target price on Corteva from $80.00 to $82.00 and gave the company an “outperform” rating in a report on Tuesday, February 17th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Jefferies Financial Group lifted their price target on Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. Finally, Argus raised Corteva to a “strong-buy” rating in a research note on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, Corteva presently has an average rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.